While I agree that BP clearly explained how Leronlimab will impact the virus in its various stages. we’re talking about a subjective data point the scoring system 1-12 on PE for people who largely get better on their own.. You’re holding out for statistical significance for the PE?? ...i actually don’t understand your point.. they been crunching data for a month now they didn’t get to that easy one first?
Read More: https://investorshangout.com/post/view?id=584...z6Tsff2tpQ
Bigtimer, I have neither the data nor medical science to argue that day 14 results will be statistically significant. I only think that it' s way premature to argue that it won't solely because allegedly most patients "FULLY recover" by day 14 without any treatment. I believe that this mantra should be questioned and subject to scientific investigation if only of the so-called long-haulers population whose size is yet unknown to us. What if the data for day 14 show the placebo group virus free yet NEWS2 is still not entirely normalized in comparison with the lero group? Or that the placebo group still shows some "limitation on activities," say on the scale 3 in comparison with 1 for the lero treated? Or that it took 10 days for the placebo group to "return to normal activities" and only 5 for the lero group? I have no idea what these differences will be, even less what they do to the p value. All I am saying: lets take the mantra about "FULLY" virus free population with a tiny bit of salt.
This is my last for today. Thank you and other contributors to this great board and GLTA!
Read More: https://investorshangout.com/post/view?id=584...z6Tsff2tpQ
Bigtimer, I have neither the data nor medical science to argue that day 14 results will be statistically significant. I only think that it' s way premature to argue that it won't solely because allegedly most patients "FULLY recover" by day 14 without any treatment. I believe that this mantra should be questioned and subject to scientific investigation if only of the so-called long-haulers population whose size is yet unknown to us. What if the data for day 14 show the placebo group virus free yet NEWS2 is still not entirely normalized in comparison with the lero group? Or that the placebo group still shows some "limitation on activities," say on the scale 3 in comparison with 1 for the lero treated? Or that it took 10 days for the placebo group to "return to normal activities" and only 5 for the lero group? I have no idea what these differences will be, even less what they do to the p value. All I am saying: lets take the mantra about "FULLY" virus free population with a tiny bit of salt.
This is my last for today. Thank you and other contributors to this great board and GLTA!
1
CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
